Moderna and Merck prepare for PhIII trial of cancer vaccine, and an expansion to lung cancer: #AACR23

ORLANDO – Moderna and Merck plan to launch a Phase III study this year for their personalized cancer vaccine in melanoma, and have revealed more details from a Phase IIb test that earlier this year renewed excitement about the use of vaccines in fighting tumors. The news comes just a month after…#orlando #merck #melanoma #moderna #stephenhoge #ericrubin
Source: Reuters: Health - Category: Consumer Health News Source Type: news